SCIENTIFIC EVIDENCE

Dual-Pronged Lipid Nanocarriers Promote Immunotherapy for TNBC by Inducing Immunogenic Cell Death and Activating Lymphoid Immune Cells.

Research (Washington, D.C.)
Ye J, Wang S, Wu S, Li R, Li X, Chen S, Wang Y, Wang L, Qin C, Wang H, Yang Y, Wang J, Du T, Ma F, Liu Y.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2026
Cancer Research
Immunology
Key Finding
Of note, PTX Emul combined with CHA-SME augmented the immunotherapeutic effects through highly efficient ICD induction within the tumor microenvironment of 4T1 orthotopic tumor, the potent DC maturation, and the effective activation of T cell-based antitumor immunity, resulting in a substantial enhancement in the inhibition of 4T1 orthotopic tumors and, notably, a reduction in lung metastasis.
Countstar Connection
For the study's cell samples, researchers obtained cell-count measurements with Countstar Mira FL during quality assessment for the immune-cell research.
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online